Ryan Specialty Earnings Beats Widen, Insider Sells $1.62M
Ryan Specialty Holdings posted a 23.3% earnings beat, extending a pattern of widening outperformance over estimates. The co-president's sale of $1.62M in shares just weeks before Q3 earnings on Octobe
Ryan Specialty Q3 Earnings Due Oct. 29 as Shorts Hit 12%
NEW YORK, October 18 —
With Q3 results due October 29, Ryan Specialty Holdings, Inc. (RYAN) arrives carrying back-to-back earnings beats, the latest a 23.3% upside surprise, even as its Co-President sold $1.62 million in shares at nearly the current price just weeks before the call.
- Q2 EPS $0.74 beat the $0.60 consensus by 23.3%, the widest margin in four reported quarters
- Analyst consensus price target $49.09 sits $8.34 above the current $40.75
- Net insider selling: $1.71M over 90 days against zero in purchases
Each Beat Wider Than the Last
Ryan Specialty Holdings is a wholesale insurance broker and managing underwriter, sitting between retail agents and carriers to bind specialty coverage for commercial, industrial, and institutional clients across the U.S., U.K., and Europe, taking on risks standard markets typically decline. Founded in 2010, the Chicago firm employs 6,171 people across distribution, underwriting, product development, and risk management, without direct consumer exposure. Its four-quarter EPS record shows a 0.6% beat, an 8.2% miss, then back-to-back outperformance of 9.2% and, per the July 30 8-K, 23.3%, each margin wider than the last, a pattern that points to something structural rather than seasonal. Compare sector valuations with the P/E calculator.
The Selling Pattern
The insider ledger cuts against the bullish read. Co-President and CRO Brendan Martin Mulshine converted two 40,000-share equity award tranches on September 4, then sold 40,000 of those shares four days later at $40.51, within 25 cents of current levels, for $1.62 million. EVP Michael Conklin sold 2,043 shares at $42.26 in August. Across the 90-day window, net purchases total zero; outright sales reach $1.71 million. Mulshine's exit is the sharpest signal: the executive overseeing underwriting operations chose to price the stock at essentially current levels weeks before a call the analyst community expects to push it 20% higher.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| RYAN | $10.4B | 16.7x | -22.4% |
| CNM | $7.7B | 12.0x | -20.2% |
| EQH | $14.5B | 6.0x | +10.8% |
| HAYW | $2.5B | 12.5x | -23.3% |
| STEP | $5.4B | 12.2x | -31.7% |
| GSHD | $1.7B | 17.3x | -29.0% |
What October 29 Decides
The Q3 call is the clearest arbitration point between the two reads. A third consecutive beat, especially one that again clears consensus by double digits, would test whether the $8.34 gap to the $49.09 analyst target begins to close. Guidance language matters as much as the headline number: a beat paired with cautious forward commentary would leave the stock near the $40.51 level where the co-president chose to sell. The beat cadence, whether it accelerates, holds, or reverses, is the number to watch. Run the free Ryan Specialty Holdings, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What was Ryan Specialty's latest earnings beat?
Ryan Specialty reported Q2 EPS of $0.74, beating the $0.60 consensus estimate by 23.3%, the widest margin in four reported quarters. The company has shown a pattern of widening outperformance, with beats of 0.6%, a miss of 8.2%, then back-to-back gains of 9.2% and 23.3%.
When are Ryan Specialty Q3 earnings due?
Q3 earnings are scheduled for October 29. This earnings call may be the clearest arbitration point between the bullish analyst consensus and the cautious insider selling pattern.
Why is the insider selling significant?
Co-President and CRO Brendan Martin Mulshine sold 40,000 shares at $40.51 in September, just weeks before the Q3 earnings call, at nearly the current $40.75 level. Over the past 90 days, net insider purchases total zero while sales reached $1.71 million, contrasting sharply with analyst expectations for a 20% stock price gain.
What is the analyst price target?
Analyst consensus price target is $49.09, sitting $8.34 above the current stock price of $40.75. This implies analyst expectations for approximately 20% upside from current levels.
What does Ryan Specialty do?
Ryan Specialty Holdings is a wholesale insurance broker and managing underwriter, sitting between retail agents and carriers to bind specialty coverage for commercial, industrial, and institutional clients across the U.S., U.K., and Europe. The Chicago firm employs 6,171 people across distribution, underwriting, product development, and risk management.
Ryan Specialty Holdings has scheduled its Q3 2026 results call for October 29, arriving on the heels of three consecutive earnings beats — including a 23.3% upside surprise last quarter. Yet short interest stands at 12.4% of the float and the company's co-president just sold $1.62 million in shares at nearly the current price, leaving investors to decide who has the better read on what comes next.